Table 3 Association between MS course type and willingness to take SARS-CoV-2 vaccine (percentage within course type groups at 1st follow-up/2nd follow-up).

From: Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic

 

A

B

C

N

CIS

36.5/0.0

27.0/33.3

36.5/67.0

11/6

RRMS

23.0/25.0

16.0/20.0

61.0/55.0

128/100

SPMS

22.0/14.0

17.0/13.0

61.0/73.0

40/38

PPMS

7.0/27.0

20.0/9.0

73.0/64.0

15/11

  1. A—Certainly not or unlikely taking a SARS-CoV-2 vaccine; B—Not known yet; C—Probably or with certainty taking a SARS-CoV-2 vaccine; CIS clinically isolated syndrome, MS multiple sclerosis, PPMS Primary progressive MS, N total number of patients, RRMS relapsing–remitting MS, SPMS Secondary progressive MS. Meaning of percentages in a field − example field RRMS/A: 23.0% of RRMS-patients at the 1st follow-up and 25.0% at the 2nd follow-up were certainly not or unlikely taking a SARS-CoV-2 vaccine.
Back to article page